These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18586349)

  • 1. Treatment of non-small cell lung cancer patients with performance status2 (PS2).
    Boukovinas I; Kosmidis P
    Lung Cancer; 2009 Jan; 63(1):10-5. PubMed ID: 18586349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of PS2 patients with advanced non-small cell lung cancer.
    Cheong KA; Chrystal K; Harper PG
    Int J Clin Pract; 2006 Nov; 60(11):1493-6. PubMed ID: 16911572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in pretreatment quality of life in a prospective lung cancer trial.
    Siddiqui F; Kohl R; Swann S; Watkins-Bruner D; Movsas B
    J Support Oncol; 2008 Jan; 6(1):33-9. PubMed ID: 18257399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced non-small cell lung cancer in the elderly.
    Sequist LV; Fidias P
    Semin Respir Crit Care Med; 2005 Jun; 26(3):289-97. PubMed ID: 16052430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential treatment options after first-line chemotherapy for advanced NSCLC: maintenance treatment or early second-line?
    Gridelli C; Maione P; Rossi A; Ferrara ML; Bareschino MA; Schettino C; Sacco PC; Ciardiello F
    Oncologist; 2009 Feb; 14(2):137-47. PubMed ID: 19190239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving chemotherapy for patients with advanced non-small cell lung cancer.
    von Plessen C
    Clin Respir J; 2011 Jan; 5(1):60-1. PubMed ID: 21159143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results.
    Ohguri T; Imada H; Narisada H; Yahara K; Morioka T; Nakano K; Miyaguni Y; Korogi Y
    Int J Hyperthermia; 2009 Mar; 25(2):160-7. PubMed ID: 19337916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 800-lb gorilla we all ignore: treatment of NSCLC in elderly and PS 2 patients.
    Devlin JG; Langer CJ
    Clin Adv Hematol Oncol; 2007 Mar; 5(3):216-33. PubMed ID: 17519883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of maintenance chemotherapy in advanced nonsmall cell lung cancer.
    Jalal SI; Ademuyiwa FO; Hanna NH
    Curr Opin Oncol; 2009 Mar; 21(2):110-5. PubMed ID: 19532011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.
    Wu C; Jiang J; Shi L; Xu N
    Anticancer Res; 2008; 28(6B):3997-4002. PubMed ID: 19192663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in non-small cell lung cancer.
    Walker S
    Clin J Oncol Nurs; 2008 Aug; 12(4):587-96. PubMed ID: 18676326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer treatment in New Zealand: physician's attitudes.
    Christmas T; Findlay M
    N Z Med J; 2004 Jun; 117(1196):U931. PubMed ID: 15280935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress and perspectives in the management of patients with lung cancer].
    Barlesi F; Gimenez C; Pibarot M; Kleisbauer JP
    Bull Cancer; 2002 Jan; 89(1):57-66. PubMed ID: 11847027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
    Di Maio M; Chiodini P; Georgoulias V; Hatzidaki D; Takeda K; Wachters FM; Gebbia V; Smit EF; Morabito A; Gallo C; Perrone F; Gridelli C
    J Clin Oncol; 2009 Apr; 27(11):1836-43. PubMed ID: 19273711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-small cell lung cancer in the elderly.
    Makrantonakis PD; Galani E; Harper PG
    Oncologist; 2004; 9(5):556-60. PubMed ID: 15477641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of bronchial carcinoma in the elderly].
    Diab S; Geriniere L; Carrie C; Souquet PJ
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):616-26. PubMed ID: 12473948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?
    Maione P; Rossi A; Di Maio M; Gridelli C
    Lung Cancer; 2009 Oct; 66(1):8-14. PubMed ID: 19328587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer.
    Dooms CA; Pat KE; Vansteenkiste JF
    Expert Rev Anticancer Ther; 2006 Apr; 6(4):531-44. PubMed ID: 16613541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of lung cancer in the elderly].
    Diab S; Geriniere L; Carrie C; Souquet PJ
    Rev Mal Respir; 2004 Nov; 21(5 Pt 3):8S59-69. PubMed ID: 15803539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
    Früh M; Rolland E; Pignon JP; Seymour L; Ding K; Tribodet H; Winton T; Le Chevalier T; Scagliotti GV; Douillard JY; Spiro S; Shepherd FA
    J Clin Oncol; 2008 Jul; 26(21):3573-81. PubMed ID: 18640938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.